Ginsenoside Rg1 delays tert-butyl hydroperoxide-induced premature senescence in human WI-38 diploid fibroblast cells

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 3, 2008, Pages 253-264

  Chen, Xiaochun ^a   Zhang, Jing ^a   Fang, Yaxiu ^a   Zhao, Chaohui ^a   Zhu, Yuangui ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

ATP; Ginsenoside Rg1; Mitochondrial respiratory chain complex; p16; p21; Senescence; Tert butyl hydroperoxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL CYCLE PROTEIN; GINSENOSIDE RG 1; LACTATE DEHYDROGENASE; MITOCHONDRIAL COMPLEX IV; OXIDOREDUCTASE; PROTEIN P16; PROTEIN P21; TERT BUTYL HYDROPEROXIDE;

ARTICLE; CELL AGING; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PREMATURE AGING; PRIORITY JOURNAL; SENESCENCE; WESTERN BLOTTING;

PANAX GINSENG; RATTUS;

EID: 44349095712     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.3.253     Document Type: Article

References (40)

1. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol. 1992;36:27-38.
2. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci. 2001;16 Suppl:S28-S37.
3. Jaenicke B, Kim EJ, Ahn JW, Lee HS. Effect of Panax ginseng extract on passive avoidance retention in old rats. Arch Pharm Res. 1991;14:25-29.
4. Nitta H, Matsumoto K, Shimizu M, Ni XH, Watanabe H. Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task. Biol Pharm Bull. 1995;18:1286-1288.
5. Zhao CH, Chen XC, Jin JS, et al. Effect of ginsenoside Rg1 on expression of p21, cyclin E and CDK2 in the process of cell senescence. Yao Xue Xue Bao. 2004;39:673-676.
6. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol. 1992;27:375-382.
7. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007;292:R18-R36.
8. Singh KK. Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci. 2006;1067:182-190.
9. Keefe DL, Marquard K, Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gynecol. 2006;18:280-285.
10. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 1997;277:831-834.
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805-816.
12. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363-9367.
13. Dumont P, Burton M, Chen QM, et al. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic Biol Med. 2000;28:361-373.
14. Duan J, Zhang Z, Tong T. Senescence delay of human diploid fibroblast induced by anti-sense p16INK4a expression. J Biol Chem. 2001;276:48325-48331.
15. Mazzio EA, Soliman KF. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4- phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells. Biochem Pharmacol. 2004;67:1167-1184.
16. Van Remmen H, Richardson A. Oxidative damage to mitochondria and aging. Exp Gerontol. 2001;36:957-968.
17. Morisaki H, Ando A, Nagata Y, et al. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1. Exp Cell Res. 1999;253:503-510.
18. Toussaint O, Medrano EE, von Zglinicki T: Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol. 2000;35:927-945.
19. Gerland LM, Ffrench M, Magaud JP. Cyclin dependent kinase inhibitors and replicative senescence. Pathol Biol (Paris). 2001;49:830-839.
20. Tsutsui T, Kumakura S, Yamamoto A, et al. Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis. 2002;23:2111-2117.
21. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001;409:1067-1070.
22. Ma Y, Prigent SA, Born TL, Monell CR, Feramisco JR, Bertolaet BL. Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide. Cancer Res. 1999;59:5341-5348.
23. Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene. 2000;19:5314-5323.
24. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79:551-555.
25. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992;11:1921-1929.
26. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
27. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
28. Norrback KF, Roos G. Telomeres and telomerase in normal and malignant haematopoietic cells. Eur J Cancer. 1997;33:774-780.
29. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res. 1995;220:186-193.
30. Dumont P, Royer V, Pascal T, et al. Growth kinetics rather than stress accelerate telomere shortening in cultures of human diploid fibroblasts in oxidative stress-induced premature senescence. FEBS Lett. 2001;502:109-112.
31. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995;269:1236-1241.
32. Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science. 1997;275:973-977.
33. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998;58:1558-1561.
34. Horikawa I, Cable PL, Afshari C, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 1999;59:826-830.
35. Marchetti P, Susin SA, Decaudin D, et al. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 1996;56:2033-2038.
36. Yoon YS, Cho H, Lee JH, Yoon G. Mitochondrial dysfunction via disruption of complex II activity during iron chelation-induced senescence-like growth arrest of Chang cells. Ann N Y Acad Sci. 2004;1011:123-132.
37. Kwong LK, Sohal RS. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch Biochem Biophys. 2000;373:16-22.
38. Benzi G, Pastoris O, Marzatico F, Villa RF, Dagani F, Curti D. The mitochondrial electron transfer alteration as a factor involved in the brain aging. Neurobiol Aging. 1992;13:361-368.
39. Chen XC, Zhu YG, Zhu LA, et al. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol. 2003;473:1-7.
40. Chen XC, Zhou YC, Chen Y, Zhu YG, Fang F, Chen LM. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin. 2005;26:56-62.